关键信息
-
基因名
ART1
- 应用
-
别名
CD296; ART2; ARTC1; Mono(ADP-ribosyl)transferase 1; ADP-ribosyltransferase C2 and C3 toxin-like 1; GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q60935
-
表达区间
Gln23~Cys325
-
分子量
37kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
ART1, also known as antigen presentation receptor 1, is a crucial protein in the field of immunology, particularly in understanding how the immune system recognizes and responds to foreign antigens. Research into ART1 has gained momentum due to its role in T-cell activation and its potential implications in various diseases, including autoimmune disorders and cancers. The ART1 protein functions as a co-stimulatory receptor on antigen-presenting cells, enhancing the activation and proliferation of T cells upon interaction with specific ligands. This function is vital for the initiation of adaptive immune responses. In the context of cancer immunotherapy, targeting ART1 and its signaling pathways has emerged as a promising strategy to enhance anti-tumor immunity. Moreover, recent studies have linked variations in ART1 expression to the severity of autoimmune diseases, making it a potential biomarker for disease progression. As researchers continue to unravel the intricate mechanisms by which ART1 influences immune responses, there is a growing interest in developing ART1-targeted therapeutics that could improve patient outcomes in various immunological conditions. Understanding ART1's structure and function at the molecular level is imperative for these advancements, laying the groundwork for novel strategies to modulate immune responses in health and disease.
